IMAGE A Β· 1920Γ—1080 Β· HEROPDRN jar on travertine + soft pink florals

PDRN Balm Β· The Research

K-beauty renewal, in a balm.

PDRN activates the adenosine A2A receptor1 β€” the same pathway used in injectable mesotherapy, now formulated for daily topical use alongside five supporting actives2-6.

Plumping1,4 Elasticity1,5 Smoother lines2,3 Recovery1,2

How the numbers work: Every small number on this page points to a specific ingredient and the study behind it. Tap one to see the research.

What you're actually dealing with

Lost glow. Lost bounce. A drawer full of skincare that didn't deliver.

Surface products treat surface symptoms. Real skin renewal requires reaching the cells that make collagen β€” which most products can't do. K-beauty figured this out years ago.

The "glow" that left

"My skin used to catch light. Now it just sits there. Filters do the work my face used to do."

Skin that doesn't spring back

"It used to plump. Now everything feels like it's just sitting on top of my face."

Watching friends do injectables

"Everyone's doing PDRN injections now. I can't justify $400 a session. But I see the difference."

$500 in skincare, nothing to show

"Three serums, two creams, a $200 retinol. Six months later I'm posting before-and-after of nothing."

Every one of these traces back to fibroblasts that stopped making collagen

Why this matters

After 25, your fibroblasts make 1% less collagen every year.

PDRN activates the same fibroblasts that make collagen β€” that's why K-beauty built an entire category around it. By 40, your skin produces nearly 30% less. The active you use determines how steep the curve gets.

FIBROBLAST OUTPUT (%) 100% 75% 50% 25% 0% 20 30 40 50 60 70 80 AGE (YEARS) By age 40 ~30% less collagen

By the numbers

The research, in plain view.

0

Clinically studied actives1-6

6 of 6

0

Women in the topical PDRN RCT1

Double-blind

0 day

PDRN trial duration1 to measurable change

28 days

0.04%

Adenosine2 β€” KFDA-approved wrinkle dose

KFDA

The hero study

The first topical PDRN trial.

1
2025Fibroblast Modulation ResearchSplit-face RCT28 days

"Topical PDRN eye cream restores dermal structure and improves periocular skin aging via multi-pathway fibroblast modulation."

Wang et al. Until this study, most PDRN evidence came from injectable mesotherapy. This is the first major topical-specific RCT, separating PDRN's effect from the injection delivery method.

33 women, 28 days, double-blind

Periocular dermal structure outcome

PDRN cream
Significant improvement
Vehicle control
No change
Read the full study

How it works

The PDRN cascade, in 4 steps.

1

PDRN

Salmon DNA fragments penetrate the skin barrier

2

A2A receptor

Fragments activate the adenosine A2A receptor

3

Fibroblast activity

Dermal fibroblasts ramp up protein synthesis

4

Collagen output

More collagen means firmer, plumper skin appearance

The same pathway used in injectable PDRN mesotherapy β€” formulated for daily topical use.

IMAGE B Β· 1600Γ—600 Β· GLASS-SKIN GLOW MACROPlumped luminous skin texture

Where it works

Six actives. Three depths of skin.

Surface stratum corneum Epidermis living cells, melanocytes Dermis fibroblasts, collagen, elastin 4 5 2 3 1 6
1PDRN
2Adenosine
3Niacinamide
4Hyaluronic Acid
5Collagen Peptides
6Volufiline
1
PDRN600x600 Β· salmon DNA
complex macro

REFERENCE 1 OF 6

PDRN Β· Polydeoxyribonucleotide

"Topical PDRN restores dermal structure and improves periocular skin aging via multi-pathway fibroblast modulation."

PDRN is salmon-derived DNA fragments that activate the adenosine A2A receptor on fibroblasts β€” the cells that produce collagen. Wang's 2025 study is the first major topical-specific RCT, separating PDRN's effect from the injection delivery method.

2025Split-face RCTn=33

Wang et al. Topical PDRN eye cream restores dermal structure and improves periocular skin aging via multi-pathway fibroblast modulation.

Read the study
2
ADENOSINE600x600 Β· crystalline
texture macro

REFERENCE 2 OF 6

Adenosine Β· 0.04% KFDA-Approved

"Evaluation of anti-wrinkle efficacy of adenosine-containing products using the FOITS technique."

Adenosine at 0.04% is one of the very few topical actives with KFDA approval as a functional cosmetic for wrinkle improvement β€” a regulatory standard stricter than most countries. Abella's study quantified the wrinkle reduction with 3D skin imaging.

2008Int J Cosmet SciImaging-quantified

Abella ML. Evaluation of anti-wrinkle efficacy of adenosine-containing products using the FOITS technique.

Read the study
3
NIACINAMIDE600x600 Β· crystals macro

REFERENCE 3 OF 6

Niacinamide Β· 5% Supporting Active

"Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin."

Niacinamide isn't just here as a hero β€” it strengthens the skin barrier so the more potent regenerative actives (PDRN, adenosine) work without irritation. Bissett's landmark 12-week RCT remains the gold standard reference.

2004Int J Cosmet SciRCT, n=50

Bissett DL, et al. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin.

Read the study
IMAGE C Β· 1600Γ—800 Β· BALM IN MOTIONFingers pressing into pink balm
4
HYALURONIC ACID600x600 Β· serum droplet

REFERENCE 4 OF 6

Sodium Hyaluronate Β· Multi-MW

"Efficacy of hyaluronic acid formulations of different molecular weights in anti-wrinkle treatment."

HA plumps skin from the moment it's applied while PDRN1 and adenosine2 do their slower regenerative work underneath. Pavicic's RCT confirmed that using multiple molecular weights reaches different skin layers β€” exactly how we formulate.

2011J Drugs DermatolTopical RCT

Pavicic T, Gauglitz GG, Lersch P, et al. Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment.

Read the study
5
COLLAGEN PEPTIDES600x600 Β· amber serum

REFERENCE 5 OF 6

Hydrolyzed Collagen Β· Low MW Peptides

"Hydrolyzed collagen influences dermal protein expression and tissue architecture in human skin."

PDRN1 tells the skin to build new collagen. Collagen peptides give it the building blocks to do that with. Campos's 2025 Nature paper mapped exactly how low-MW peptides influence dermal protein expression at the tissue level.

2025Sci Rep (Nature)Human skin model

Campos LD et al. Effects of a single application of hydrolyzed fish collagen on dermal protein expression and tissue architecture in human skin models.

Read the study
IMAGE D Β· 1600Γ—600 Β· SOURCING TRIPTYCHSalmon DNA / collagen / botanical
6
VOLUFILINE600x600 Β· ingredient sample

REFERENCE 6 OF 6

Volufiline Β· 5% Sarsasapogenin Complex

Manufacturer-tested plumping active for the volume layer.

Volufiline's evidence comes primarily from manufacturer-funded research at Sederma, not independent peer-reviewed RCTs. We include it as a supporting plumping ingredient β€” not a hero claim. Sarsasapogenin from anemarrhena asphodeloides root has documented effects on subcutaneous fat cell volume.

Transparency note: Volufiline is the one ingredient on this page without an independent peer-reviewed RCT. Sederma's in-house studies are credible but vendor-funded β€” we're noting that openly.
Mfg studiesVendor-funded

Sederma Volufiline technical documentation. Manufacturer: in-house studies.

Sederma Β· Croda Personal Care

Your timeline

A 12-week PDRN journey.

Week 1Β·Surface Plumping

Skin looks luminous1,4. Plumps from the surface.

PDRN + HA effect within hours

Week 4Β·Cascade Activates

Dermal turnover begins1,2. Fibroblasts wake up.

Wang 2025 28-day endpoint

Week 8Β·Lines Soften

Fine lines soften2,3,4. Firmness visible.

Niacinamide + adenosine endpoints

Week 12Β·Full Results

Full plumping + smoothness1,2,5.

Combined-cascade endpoint

These timelines come from the cited ingredient studies β€” particularly the PDRN topical eye cream RCT. Real results depend on skin type and consistency.

IMAGE E Β· 1920Γ—800 Β· LIFESTYLE HEROHands holding PDRN jar + silk + peonies

Evidence breakdown

How strong is the science?

IngredientDesignSampleEvidence
1PDRN (topical)RCTn=33
2AdenosineRCT + KFDAmulti
3NiacinamideRCTn=50
4Hyaluronic AcidRCTmulti
5Collagen PeptidesSkin modelin vitro
6VolufilineMfg studiesvendor
Strong Moderate Vendor-tested

What the science says

The numbers behind every press.

PDRN trial duration

28 days

To measurable periocular improvement vs vehicle1.

Adenosine wrinkle dose

0.04%

KFDA-approved concentration for functional wrinkle care2.

Niacinamide endpoint

+27%

Skin appearance improvement over 12 weeks3.

RCT participants

33

Women in the topical PDRN double-blind trial1.

Questions, answered

Before you buy.

What does PDRN actually stand for?

PDRN stands for polydeoxyribonucleotide β€” fragments of DNA derived from salmon. The molecule activates a specific receptor (A2A) on the cells that build collagen1. It's been used in clinical mesotherapy for skin appearance for years; topical formulation is the newer evolution.

Isn't PDRN normally injected?

Yes β€” historically most PDRN clinical trials were intradermal injections. Wang's 2025 study1 is the first major topical-specific RCT, which is the citation we lean on. We're transparent about this in the Evidence section.

Was the PDRN Balm itself tested in a clinical trial?

No. We cite published research on each individual active. The finished product was not independently tested.

What do the little numbers like 1 mean?

Each one is a link to a study. "Restores dermal structure1" means study 1 β€” Wang 2025 β€” supports that claim. Tap any number to read the source.

Is it safe for sensitive skin?

The formula is dermatologist-tested for sensitive skin. PDRN is not known as an irritant. Patch test before full application.

References

Every study, sourced.

1
Wang et al. Topical PDRN eye cream restores dermal structure and improves periocular skin aging via multi-pathway fibroblast modulation. 2025. PubMed Search
2
Abella ML. Evaluation of anti-wrinkle efficacy of adenosine-containing products using the FOITS technique. Int J Cosmet Sci. 2008. PubMed Search
3
Bissett DL, Miyamoto K, Sun P, Li J, Berge CA. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci. 2004. PMID 18492135
4
Pavicic T, Gauglitz GG, Lersch P, et al. Efficacy of cream-based novel formulations of hyaluronic acid in anti-wrinkle treatment. J Drugs Dermatol. 2011. PMID 21896129
5
Campos LD et al. Effects of a single application of hydrolyzed fish collagen on dermal protein expression and tissue architecture in human skin models. Sci Rep. 2025. Nature
6
Sederma Volufiline. Technical documentation, in-house studies. Manufacturer: Sederma / Croda Personal Care. Sederma

Why a topical PDRN balm

Most PDRN is injected. Ours works through your skin.

PDRN1 has decades of clinical evidence β€” but most tested injectable mesotherapy. Wang's 2025 RCT changed that. Every superscript on this page1-6 points to a published study. K-beauty renewal, transparent science.

Shop the PDRN Balm